LUCD
Lucid Diagnostics Inc.Company Information
- Company Name
- Lucid Diagnostics Inc.
- CIK
- CIK0001799011
- Category
- <br>Emerging growth company
- Ticker: Exchange
- LUCD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- LUCD
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-20
- Last sale
- 2023-09-26
- Shares purchased (TTM)
- 378,218
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 61,611,473
- Shares outstanding
- 183,124,412
- Ownership
- 33.64%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -4.47%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 33 | 28 | 35 | 47 | 31 | 25 | 22 | 14 | 25 | 25 | 19 | 24 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Assets Current | 37 | 31 | 37 | 50 | 34 | 28 | 25 | 17 | 28 | 28 | 22 | 27 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 1 | 1 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 39 | 34 | 40 | 53 | 39 | 33 | 31 | 23 | 34 | 32 | 27 | 33 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Liabilities Current | 2 | 2 | 3 | - | - | - | 3 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Notes Payable Current | 24 | 25 | 24 | 22 | 25 | 33 | 19 | 10 | 11 | 13 | 14 | 14 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | - | - | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 3 | ||||||
| Liabilities Current | 28 | 29 | 29 | 26 | 29 | 37 | 24 | 14 | 16 | 20 | 29 | 30 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | ||||||
| Liabilities | 28 | 30 | 30 | 27 | 31 | 38 | 25 | 16 | 18 | 20 | 30 | 31 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 10 | 54 | 54 | 54 | 54 | 54 | 56 | 56 | 44 | 19 | 14 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 323 | 292 | 231 | 229 | 201 | 180 | 155 | 143 | 140 | 136 | 130 | 129 | ||||||
| Retained Earnings Accumulated Deficit | -313 | -298 | -274 | -258 | -248 | -240 | -204 | -192 | -180 | -169 | -151 | -140 | ||||||
| Stockholders Equity | 11 | 4 | 11 | 26 | 8 | -5 | 5 | 6 | 16 | 12 | -2 | 3 | ||||||
| Liabilities And Stockholders Equity | 39 | 34 | 40 | 53 | 39 | 33 | 31 | 23 | 34 | 32 | 27 | 33 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 191 | 165 | 131 | 131 | 102 | 84 | 63 | 52 | 49 | 47 | 42 | 42 | ||||||
| Shares Outstanding | 191 | 165 | 131 | 131 | 102 | 84 | 63 | 52 | 49 | 47 | 42 | 42 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLucid Diagnostics Inc. (LUCD) — SEC Financial Statements & Analysis
Lucid Diagnostics Inc. (LUCD) is a surgical & medical instruments & apparatus company, incorporated in DE. Lucid Diagnostics Inc. trades on Nasdaq as: LUCD. Lucid Diagnostics Inc. (LUCD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Lucid Diagnostics Inc. carries a market cap of $195.94M, a P/E ratio of -3.16x, a P/B ratio of 17.93x, a P/S ratio of 49.72x, an enterprise value of $186.04M, and an EV/EBITDA multiple of -3.74x. On profitability, it posts a gross margin of 29.42%, an operating margin of -1286.07%, a net margin of -1572.65%, a Return on Equity (ROE) of -659.73%, a Return on Assets (ROA) of -159.70%, and a Return on Invested Capital (ROIC) of -3140.25%. Per share, it reports EPS of $-0.34, diluted EPS of $-0.49, free cash flow per share of $-0.26, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -9.61% year-over-year, net income growth of 12.16% year-over-year, and EPS growth of -39.37% year-over-year. On the balance sheet, it maintains a current ratio of 1.33x, a quick ratio of 1.25x, working capital of $9.11M, a debt-to-equity ratio of 2.56x, a debt ratio of 0.72, an interest coverage ratio of -4223.67x, free cash flow of $-47.10M (TTM), and net debt of $-9.90M. Figures sourced from SEC EDGAR.
- Market Cap
- $195.94M
- P/E TTM
- -3.16x
- EPS TTM
- $-0.34
- P/B TTM
- 17.93x
- ROE TTM
- -659.73%
- ROA TTM
- -159.70%
- Debt To Equity
- 2.56x
- Free Cash Flow TTM
- $-47.10M
- Net Revenue TTM Growth 1Y
- -9.61%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Lucid Diagnostics Inc. in?
Lucid Diagnostics Inc. (LUCD) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does LUCD trade on?
Lucid Diagnostics Inc. (LUCD) trades on the Nasdaq.
Where is Lucid Diagnostics Inc. incorporated?
Lucid Diagnostics Inc. is incorporated in DE.
When was Lucid Diagnostics Inc. (LUCD)'s most recent SEC filing?
Lucid Diagnostics Inc. (LUCD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is LUCD's market cap?
Lucid Diagnostics Inc. (LUCD) has a market capitalization of $195.94M as of 2026-06-30.
What is LUCD's EPS (earnings per share)?
Lucid Diagnostics Inc. (LUCD)'s trailing twelve month EPS is $-0.34 as of 2026-06-30.
What is LUCD's ROE (return on equity)?
Lucid Diagnostics Inc. (LUCD)'s trailing twelve month Return on Equity (ROE) is -659.73% as of 2026-06-30.
What is LUCD's ROA (return on assets)?
Lucid Diagnostics Inc. (LUCD)'s trailing twelve month Return on Assets (ROA) is -159.70% as of 2026-06-30.
What is LUCD's ROIC (return on invested capital)?
Lucid Diagnostics Inc. (LUCD)'s trailing twelve month Return on Invested Capital (ROIC) is -3140.25% as of 2026-06-30.
What is LUCD's EV/EBITDA?
Lucid Diagnostics Inc. (LUCD)'s trailing twelve month EV/EBITDA is -3.74x as of 2026-06-30.